Goldman Sachs downgraded Eli Lilly (NYSE: LLY) from Conviction Buy to Buy with a price target of $92.00.The firm ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE